Medical dictionary

Medical terminology normalized via MeSH, ICD-11, SNOMED CT.

62,341 terms indexed

• C5722814,8-dihydroxyisochroman-1-oneMeSH

  structure in first source

• C5877054,8-dimethyl-6-O-(2',4'-di-O-methyl-beta-D-xylopyranosyl)hydroxyquinolineMeSH

  structure in first source

• C5747814,9-dihydro-1H-carbazol-3(2H)-oneMeSH

  structure in first source

• C5764174,alpha-diepi-streptovitacin AMeSH

  structure in first source

• C5603444-(((2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl)methylamino)methyl)-N-(phenyl)benzenesulfonamideMeSH

  structure in first source

• C5752824-(((2-(2-methyl-4-(5-(1-methylethyl)-1,2,4-oxadiazol-3-yl)piperazin-1-yl)pyrimidin-5-yl)oxy)methyl)pyridine-3-carbonitrileMeSH

  a G-coupled protein receptor 119 antagonist; structure in first source

• C5598624-(((2-(benzyloxy)phenyl)methyl)amino)phenolMeSH

  an antiviral agent that targets D4 protein of vaccinia virus; structure in first source

• C5858174-(((4-cyanophenyl)(4H-1,2,4-triazol-4-yl)amino)methyl)phenyl sulfamateMeSH

  structure in first source

• C5818574-(((5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl)(carboxylatomethyl)sulfonio)-2-ammoniobutanoateMeSH

  involved in tRNA modification; structure in first source

• C5784854-(((5R,7S)-1-(3-fluorophenyl)-3,7-dimethyl-2,2-dioxido-2-thia-1,3,8-triazaspiro(4,5)dec-8-yl)methyl)-2-isopropoxyphenolMeSH

  structure in first source

• C5844774-(((8-bromo-2,2-dimethyl-4-(4-methylphenyl)chroman-6-yl)carbonyl)amino)benzoic acidMeSH

  structure in first source

• C5773294-((1,1-dioxo-1,2-benzothiazol-3-yl)sulfanyl)benzoic acidMeSH

  structure in first source

• C5711814-((1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl))-N-(8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)cyclohexylcarboxamideMeSH

  has cardiogenic activity; structure in first source

• C5779444-((1-butyl-3-phenylureido)methyl)-N-hydroxybenzamideMeSH

  inhibits HDAC6; structure in first source

• C5752864-((1-hydroxy-2,3-dihydro-1H,1'H-(2,2-biinden)-2-yl)methyl)benzoic acidMeSH

  has anti-inflammatory activity; structure in first source

• C5682164-((1E)-3-(biphenyl-4-yl)buta-1,3-dien-1-yl)phenyl 2-methylprop-2-enoateMeSH

  structure in first source

• C5682154-((1E)-3-(biphenyl-4-yl)buta-1,3-dien-1-yl)phenyl prop-2-enoateMeSH

  structure in first source

• C5688244-((2'-O-acetylrhamnosyloxy)benzyl)isothiocyanateMeSH

  isolated from Moringa oleifera; structure in first source

• C5792464-((2-carboxyethyl)hydroxyphosphinyl)-3-oxobutyrateMeSH

  inhibits fumarylacetoacetate hydrolase; structure in first source

• C5603334-((2S)-2-(1H-imidazol-1-ylmethyl)-5-oxotetrahydro-1H-pyrrol-1-yl)methylbenzenecarboxylic acidMeSH

  structure in first source

• C5817074-((3-(trifluoromethyl)phenyl)methyl)-2H-1,4-benzothiazin-3(4H)-oneMeSH

  a K(Ca)3.1 channel blocker; structure in first source

• C5606224-((3-aminophenyl)(4-(4-fluorobenzyl)piperazin-1-yl)methyl)-N,N-diethylbenzamideMeSH

  structure in first source

• C5703034-((4'-benzylpiperdin-4-yl)amino)-4'-O-demethylepipodophyllotoxinMeSH

  has antineoplastic activity; structure in first source

• C5840144-((4-(((4-amino-2,3,5,6-tetramethylanilino)acetyl)(methyl)amino)-1-piperidinyl)methyl)benzamideMeSH

  structure in first source

• C5686824-((4-((2-chlorophenyl)(hydroxy)methyl)pyrimidin-2-yl)amino)benzonitrileMeSH

  has anti-HIV activity; structure in first source

• C5844644-((4-((2-hydroxyethyl)methylcarbamoyl)phenyl)quinolin-8-yl-methylene)-1-thiazol-4-ylmethylpiperidiniumMeSH

  structure in first source

• C5816144-((4-((2-isopropyl-1H-benzoimidazole-4-carbonyl)amino)methyl)piperidin-1-ylmethyl)piperidine-1-carboxylic acid methyl esterMeSH

  structure in first source

• C5837734-((4-((4-azido-2,6-dimethylphenyl)amino)-2-pyrimidinyl)amino)benzonitrileMeSH

  a photo-labeling compound; structure in first source

• C5826234-((4-(2-naphthyl)-1,3-thiazol- 2-yl)amino)phenolMeSH

  an aminothiazole that inhibits of microsomal prostaglandin E synthase-1

• C5717754-((4-(3-bromophenylamino)quinazolin-6-ylamino)methyl)phenolMeSH

  structure in first source

• C5687824-((4-(pyrrolidin-1-ylmethyl)phenyl)amino)-4'-O-demethyl-4-epipodophyllotoxinMeSH

  has antineoplastic agent; structure in first source

• C5739974-((4-aminobenzene)sulfonyl)anilineMeSH

  structure in first source

• C5792534-((4-butylphenyl)amino)-2-methylene-4-oxobutanoic acidMeSH

  has antiviral activity

• C5782624-((4-chlorophenyl)methyl)-2-((1-(4-(4-((3-(hexahydro-1H-azepin-1-yl)propyl)oxy)phenyl)butyl)-2-pyrrolidinyl)methyl)pyrido(3,4-d)pyridazin-1(2H)-oneMeSH

  structure in first source

• C5809354-((4-hydroxyphenylimino)methyl)benzene-1,2-diolMeSH

  structure in first source

• C5736344-((5-(4-benzyloxybenzylidene)-2-(4-trifluoromethylphenylimino)-4-oxo-3-thiazolidinyl)methyl)benzoic acidMeSH

  structure in first source

• C5795404-((5-(bromomethylene)-2-oxo-2,5-dihydrothiophen-3-yl)methoxy)-4-oxobutanoic acidMeSH

  inhibits quorum sensing in .Vibrio harveyi; structure in first source

• C5829284-((6-(2-(4-(4-((4-(3-acrylamidophenoxy)-5-chloropyrimidin-2-yl)amino)-3-methoxyphenyl)piperazin-1-yl)acetoxy)hexyl)oxy)-3-(phenylsulfonyl)-1,2,5-oxadiazole 2-oxideMeSH

  structure in first source

• C5862304-((6-O-(E)-caffeoyl)-beta-D-glucopyranosyl)vanillic acidMeSH

  from Inula cappa DC; structure in first source

• C5733144-((9-cyclopentyl-7,7-difluoro-5-methyl-6-oxo-6,7,8,9-tetrahydro-5H-pyrimido(4,5-b)(1,4)diazepin-2-yl)amino)-2-fluoro-5-methoxy-N-(1-methylpiperidin-4-yl)benzamideMeSH

  a polo-like kinase 1 inhibitor; structure in first source

• C5858664-((E)-2'-(S)-glutathionyl ethenyl)catecholMeSH
• C5601454-((E)-2-(3,4-dimethoxyphenyl)ethenyl)-1-ethylpyridinium perchlorateMeSH

  structure in first source

• C5607314-(1'-cyanoisoindolyl)phenylisothiocyanateMeSH

  structure in first source

• C5768684-(1,3-benzothiazol-2-yl)thiophene-2-sulfonamideMeSH

  structure in first source

• C5695724-(1-((5-((2,6-dimethylphenoxy)methyl)-3-isoxazolyl)carbonyl)-4-piperidinyl)pyridineMeSH

  inhibits DAF-9 protein, C elegans; structure in first source

• C5712864-(1-(2-(4-((2-(4-chloro-1H-pyrazol-1-yl)ethyl)amino)-2-oxo-1,2-dihydropyridin-3-yl)-4-methyl-1H-benzo(d)imidazol-6-yl)piperidin-4-yl)piperazine-1-carboxylateMeSH

  structure in first source

• C5690324-(1-(4-fluorobenzyl)-4-hydroxy-1H-indol-3-yl)-2-hydroxy-4-oxobut-2-enoic acidMeSH

  an anti-HIV agent; structure in first source

• C5743014-(1-phenyl-1H-pyrazol-4-ylmethyl)piperazine-1-carboxylic acid ethyl esterMeSH

  an axiolytic agent; structure in first source

• C5756194-(1H-imidazol-1-yl)retinoic acid methyl esterMeSH

  an antineoplastic agent that blocks retinoic acid metabolism; structure in first source

• C5797164-(1H-indazol-6-ylamino)-N-isopropyl-2-(methylthio)pyrimidine-5-carboxamideMeSH

  an antidiabetic agent; structure in first source